Breast Biopsy Device Market Size, Value, and Competitive Overview:
[180 Pages Research Report] The global Breast Biopsy Device Market size was valued at USD YY billion in 2022, and the market is projected to reach USD YY billion by the end of 2023, with growth at a CAGR of YY% during the forecast report 2023-2030.
The production and sale of medical instruments used for conducting biopsies are referred to as the "biopsy devices market." During a biopsy, a patient's body is sampled for tissue or cells that may be used for testing and diagnosing disorders like cancer.
Medical personnel may harvest tissue samples properly and securely with the use of biopsy instruments. Depending on the type of biopsy being done—such as a needle biopsy, a surgical biopsy, or an endoscopic biopsy, among others—these tools may differ. Typically, there are numerous categories in which to place biopsy equipment:
Devices for needle-based biopsies: These tools harvest tissue samples using a variety of needle types. They can also be divided into vacuum-assisted biopsy devices, devices for fine needle aspiration (FNA), and devices for core needle biopsies.
Devices for surgical biopsies are utilized during operations to extract a bigger portion of the complete tumor for examination. They might contain implements like punches, curettes, and biopsy forceps.
Devices for localization: During the operation, localization devices are utilized to label or guide the biopsy location, guaranteeing precise targeting. They could be placed in or close to the area of interest as wires, clips, or other types of markers.
A rising incidence of cancer, improvements in diagnostic technology, and an aging population are just a few of the reasons that have contributed to the worldwide biopsy equipment market's substantial expansion in recent years. Multiple significant manufacturers and suppliers of biopsy devices operate in this fiercely competitive market.
Advancements in imaging technology, the creation of less invasive biopsy techniques, and the rise in demand for early and precise cancer detection are some of the major drivers influencing the market for biopsy equipment. The market has grown as a result of the increasing usage of liquid biopsy methods, which analyze cell-free DNA and circulating tumor cells in bodily fluids.
Breast Biopsy Device Market Dynamics
The market for biopsy equipment is shaped by the following major factors:
Rising cancer incidence: The market for biopsy instruments is significantly influenced by the global increase in cancer incidence. The need for biopsy instruments has increased as the importance of cancer diagnosis in formulating treatment programs has increased. These technologies allow for the fast and precise detection of malignant tissues.
Technological developments: Biopsies are now more accurate and efficient thanks to developments in imaging technologies including ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). Growth in the market is being fueled by the integration of imaging guiding systems with biopsy equipment, which has allowed for more accurate targeting and decreased invasiveness.
Favorable reimbursement practices: Different areas have different reimbursement practices and coverage for biopsy procedures and equipment. Positive market growth can be influenced by favorable reimbursement rules that favor biopsy procedures and associated devices.
The market for biopsy equipment is quite competitive, with a few significant competitors and a large number of smaller businesses present. Market dynamics are influenced by ongoing technical progress, new product developments, and strategic alliances and partnerships among market participants.
It's vital to remember that different geographic areas and healthcare systems might have distinct dynamics in the market for biopsy instruments. The use and expansion of biopsy instruments can be influenced by market circumstances, legal frameworks, and healthcare infrastructure in certain geographical regions.
The healthcare sector's Breast Biopsy Device Market is expanding quickly due to improvements in diagnostic technology and the rising incidence of breast cancer worldwide. Medical experts employ breast biopsy equipment as crucial tools to collect tissue samples for reliable diagnosis and evaluation of breast problems. With the help of these technologies, patients will have better results from minimally invasive procedures that promote early diagnosis.
Due to factors such growing awareness of breast cancer the deployment of screening programmes and the desire for effective diagnostic technologies the market is experiencing substantial expansion. Market expansion has been further spurred by technological developments such as the creation of vacuum-assisted biopsy systems, stereotactic biopsy systems and ultrasound-guided biopsy instruments.
Furthermore, favourable reimbursement policies, the increasing aging population, and the growing demand for personalized medicine are contributing to the market's expansion. The introduction of innovative and user-friendly biopsy devices, along with continuous research and development activities, is expected to propel the market even further.
However, challenges such as high costs associated with these devices, limited accessibility in underdeveloped regions, and the risk of false-positive or false-negative results remain key hurdles in the Breast Biopsy Device Market. Industry players are actively focusing on addressing these challenges to enhance the accuracy, affordability, and accessibility of breast biopsy devices to provide improved healthcare services to patients worldwide.
Breast Biopsy Device Market dynamic
The Breast Biopsy Device Market is experiencing dynamic growth and transformation, driven by various factors reshaping the healthcare landscape. Technological advancements are revolutionizing the field, with the introduction of cutting-edge imaging technologies, such as 3D mammography and molecular breast imaging, enhancing the accuracy and efficiency of breast biopsy procedures.
The market is also witnessing a shift towards minimally invasive techniques, such as ultrasound-guided and stereotactic biopsies, which offer faster recovery, reduced patient discomfort, and improved diagnostic outcomes. Furthermore, the integration of artificial intelligence and machine learning algorithms into biopsy devices is enabling automated analysis and interpretation of biopsy samples, streamlining the diagnostic process.
Additionally, there is an increasing emphasis on personalized medicine, with the development of companion diagnostic tests that help determine the most effective treatment strategies for individual patients. This trend is driving the demand for advanced biopsy devices capable of providing molecular profiling and genetic testing.
Moreover, the Breast Biopsy Device Market is influenced by evolving regulatory frameworks and reimbursement policies, as well as the growing awareness about breast health and the importance of early detection. Collaboration between industry players, healthcare providers, and research institutions is fostering innovation and driving the market forward.
Overall, the dynamic nature of the breast biopsy device market is a reflection of ongoing attempts to enhance patient satisfaction diagnostic accuracy, and personalized treatment options.
As per the report, the global Breast Biopsy Device Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
Breast Biopsy Device Market Segmentation
by Type
• Needle breast biopsy
• Surgical biopsy
by Product
• Biopsy needles
• Biopsy tables
• Localization wires
• Guidance systems
• Others
by Technology
• Ultrasound-guided
• Mammography-guided stereotactic
• Magnetic resonance-guided
• Others
Geographical Classification Analysis:
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
Regional Insights:
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
Breast Biopsy Device Market Competitor Analysis
• Becton, Dickinson, and Company
• Devicor Medical Products Inc.
• Hologic, Inc.
• Danaher Corporation
• Qiagen N.V.
• Illumina Inc
• Medtronic Plc
• Merit Medical Systems, Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
1. Executive Summary
1.1 Introduction to Breast Biopsy Device Markets
1.2 Breast Biopsy Device Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Breast Biopsy Device Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Breast Biopsy Device Market Trends
3.2 Key Breast Biopsy Device Market Growth Drivers
3.3 Key Breast Biopsy Device Market Growth Restraints
4 Breast Biopsy Device Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Breast Biopsy Device Market Segmentation- Outlook by Type
5.1 Needle breast biopsy Market Outlook to 2030
5.2 Surgical biopsy Market Outlook to 2030
6. Breast Biopsy Device Market Segmentation- Outlook by Product
6.1 Biopsy needles Market Outlook to 2030
6.2 Biopsy tables Market Outlook to 2030
6.3 Localization wires Market Outlook to 2030
6.4 Guidance systems Market Outlook to 2030
6.5 Others Market Outlook to 2030
7. Breast Biopsy Device Market Segmentation- Outlook by Technology
7.1 Ultrasound-guided Market Outlook to 2030
7.2 Mammography-guided stereotactic Market Outlook to 2030
7.3 Magnetic resonance-guided Market Outlook to 2030
7.4 Others Market Outlook to 2030
8. North America Breast Biopsy Device Market Outlook and Opportunities to 2030
8.1 Market Snapshot, 2023
8.2 North America Breast Biopsy Device Market Growth Opportunities
8.3 North America Breast Biopsy Device Market Outlook by Application
8.4 North America Breast Biopsy Device Market Outlook by Type
8.5 North America Breast Biopsy Device Market Outlook by Country
8.6 United States Breast Biopsy Device Market Outlook
8.7 Canada Breast Biopsy Device Market Outlook
8.8 Mexico Breast Biopsy Device Market Outlook
9. Europe Breast Biopsy Device Market Outlook and Opportunities to 2030
9.1 Market Snapshot, 2023
9.2 Europe Breast Biopsy Device Market Outlook by Application
9.3 Europe Breast Biopsy Device Market Outlook by Type
9.4 Europe Breast Biopsy Device Market Outlook by Country
9.5 Germany Breast Biopsy Device Market Outlook
9.6 France Breast Biopsy Device Market Outlook
9.7 United Kingdom Breast Biopsy Device Market Outlook
9.8 Spain Breast Biopsy Device Market Outlook
9.9 Italy Breast Biopsy Device Market Outlook
9.10 Other Europe Breast Biopsy Device Market Outlook
10. Asia Pacific Breast Biopsy Device Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 Asia Pacific Breast Biopsy Device Market Outlook by Application
10.3 Asia Pacific Breast Biopsy Device Market Outlook by Type
10.4 Asia Pacific Breast Biopsy Device Market Outlook by Country
10.5 China Breast Biopsy Device Market Outlook
10.6 Japan Breast Biopsy Device Market Outlook
10.7 India Breast Biopsy Device Market Outlook
10.8 Other Asia Pacific Breast Biopsy Device Market Outlook
11. Latin America Breast Biopsy Device Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Latin America Breast Biopsy Device Market Outlook by Application
11.3 Latin America Breast Biopsy Device Market Outlook by Type
11.4 Latin America Breast Biopsy Device Market Outlook by Country
11.5 Brazil Breast Biopsy Device Market Outlook
11.6 Argentina Breast Biopsy Device Market Outlook
11.7 Other Latin America Breast Biopsy Device Market Outlook
12. Middle East and Africa Breast Biopsy Device Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Middle East and AfricaBreast Biopsy Device Market Outlook by Application
12.3 Middle East and AfricaBreast Biopsy Device Market Outlook by Type
12.4 Middle East and AfricaBreast Biopsy Device Market Outlook by Country
12.5 Saudi Arabia Breast Biopsy Device Market Outlook
12.6 UAE Breast Biopsy Device Market Outlook
12.7 South Africa Breast Biopsy Device Market Outlook
12.8 Other Middle East and Africa Breast Biopsy Device Market Outlook
13 Profiles of major Breast Biopsy Device Companies
Becton, Dickinson, and Company
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Devicor Medical Products Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Hologic, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Danaher Corporation
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Qiagen N.V.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Illumina Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Medtronic Plc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Merit Medical Systems, Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Bio-Rad Laboratories Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
F. Hoffmann-La Roche Ltd.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
14. Appendix
14.1 Publisher’s Expertise
14.2 List of Tables and Charts
14.3 List of Exhibits
14.4 Legal Disclaimer
by Type
• Needle breast biopsy
• Surgical biopsy
by Product
• Biopsy needles
• Biopsy tables
• Localization wires
• Guidance systems
• Others
by Technology
• Ultrasound-guided
• Mammography-guided stereotactic
• Magnetic resonance-guided
• Others